Phibro Animal Health (PAHC) Tops Q2 EPS by 11c ; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq hits intraday record high on Alphabet boost, Mideast negotiation hopes
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Oil falls to two-week low as Gulf supply outlook improves
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Phibro Animal Health Corp. (PAHC) PT Raised to $22 at Barclays
February 7, 2025 2:18 PM ESTBarclays analyst Balaji Prasad raised the price target on Phibro Animal Health Corp. (NASDAQ: PAHC) to $22.00 (from $20.00) while maintaining a Underweight rating.
The analyst comments "2QFY25 Rev / Adj. EPS beat cons by ~2%/~25%. Growth was led by AH (+11% excl. new MFA; +33%... More
